Agilent Certifies BGI as Provider for SureSelect XT Target Enrichment System | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Agilent Technologies today announced BGI has become a certified service provider for Agilent's SureSelect XT Target Enrichment System for next-generation sequencing.

Based in Shenzhen, China, BGI becomes the first SureSelect XT CSF in that country, and is certified for all SureSelect XT target enrichment protocols, including human all-exon, SureSelect indexing, DNA capture, RNA capture, kinome RNA, and custom kits.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: transcriptomic analysis of the Venus flytrap, SMASH approach for CNV analysis, and more.

A Caltech professor wins the Millennium Technology Prize that lauds technological advances that improve human life.

San Diego's biotech scene has a dearth of executives who are women, Stat News reports.

Some 90 percent of respondents to a Nature survey say there is a research reproducibility crisis.